CNTX
NASDAQ · Pharmaceuticals
Context Therapeutics Inc
$2.31
-0.02 (-0.86%)
Open$2.33
Previous Close$2.33
Day High$2.33
Day Low$2.27
52W High$3.62
52W Low$0.49
Volume—
Avg Volume1.19M
Market Cap216.83M
P/E Ratio—
EPS$-0.38
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+925.1% upside
Current
$2.31
$2.31
Target
$23.68
$23.68
$16.27
$23.68 avg
$31.54
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 27.12M | 24.12M | 28.34M |
| Net Income | 5.84M | 5.30M | 5.57M |
| Profit Margin | 21.6% | 22.0% | 19.7% |
| EBITDA | 7.13M | 6.78M | 8.30M |
| Free Cash Flow | 3.88M | 4.04M | 6.28M |
| Rev Growth | -4.2% | +22.6% | +13.0% |
| Debt/Equity | 1.37 | 0.99 | 1.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |